Sorilux (calcipotriene) Foam
Plaque Psoriasis
ApprovedCommercial
Key Facts
About Mayne Pharma Group
Mayne Pharma Group is an Australian specialty pharmaceutical company with a dual focus on developing novel drug delivery technologies and commercializing a portfolio of branded and generic products. The company has built a substantial US commercial platform through acquisitions and leverages its in-house development and manufacturing capabilities. Its strategic direction centers on expanding its women's health franchise, optimizing its commercial portfolio, and advancing its pipeline of complex generic and 505(b)(2) products.
View full company profileTherapeutic Areas
Other Plaque Psoriasis Drugs
| Drug | Company | Phase |
|---|---|---|
| VTAMA (tapinarof) | Roivant Sciences | Commercial |
| Psoriasis Trial | Clinical Investigation Specialists | Not Specified |